Azimilide: Phase III

In a placebo-controlled international Phase III study in 3,717 post-MI patients with a low left ventricular ejection

Read the full 172 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE